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Abstract 
The mechanism of action of artemisinin appears to involve two steps. In the first step, activation, 
intra-parasitic iron catalyses the cleavage of the endoperoxide bridge and the generation of free radicals. In 
the second step, alkylation, the artemisinin-derived free radical forms covalent bonds with parasite proteins. 
Introduction 
Several classes of compounds containing endoperoxide 
(dioxygen) bridges have antimalarial activity, including 
artemisinin derivatives (reviewed by BUTLER & Wu, 
1992), trioxanes (reviewed by JEFFORD et al., 1992), and 
yingzhaosu derivatives (R. Ridley, Hoffman-LaRoche, 
personal wmmunication) (Fig. 1). The best understood 
A”em,~m,n Y,ngzhaoor” 
Fig. 1. Antimalarial endoperoxides 
Trloxans 
of these compounds, in terms of mechanism, are the arte- 
misinin derivatives. In this report, evidence is sum- 
marized to show that the antimalarial action of artemis- 
inin (and, by inference, other endoperoxides) depends on 
2 sequential steps. The first step, activation, comprises 
the iron-mediated cleavage of the endoperoxtde bridge m 
generate an unstable organic free radical and/or other 
electrophilic species. The second step, alkylation, in- 
volves the formation of covalent adducts between the 
drug and malarial proteins (Fig. 2). 
Fig. 2. Proposed mechanism of action af arremwun. 
Activation 
A free radical is a short-lived and highly reactive mole- 
cule that contains an unpaired electron. While many of 
the biologically im rtant free radicals are partially re- 
duced forms of mo ecular oxygen (Oz-, HO,), evidence p” 
is accumulating in a number of systems that carbon- 
centred free radicals play important roles (HALLIWELL & 
GUTTERIDGE, 1989). 
Iron has long been known m catalyse the decomposi- 
tion of both hydrogen peroxide and organic peroxides 
into free radicals. This catalytic activity is a property of 
both free iron and haem-bound iron (HALLIWELL & 
GUTTERIDGE, 1989). With this as background, the ob- 
servation that deoxyartemisinin, which lacks the endo- 
peroxide bridge, has no antimalarial activity (CO-OPERA- 
TIVE RESEARCH GROUP ON Q~NGHAOSU AND IT.S 
DERJVATIVES AS ANTIMALARIAL& 1982) led my col- 
leagues and I to investigate whether iron-catalysed cleav- 
age of the endoperoxide bridge might play a role in the 
drug’s mechanism of action. 
Indeed, iron readily catalyses the cleavage of artemis- 
inin’s endoperoxide bridge. Evidence for the haem-cata- 
lysed decomposition of artemisinin was obtained by cy- 
clic voltammetty (ZHANG er al., 1992). At least one of the 
products of the iron-mediated decomposition is a free 
radical, which was demonstrated by electron arama - 
netic resonance spectroscopy (MESHNICK et a ,, 1993 P f 
Haem also catalyses the generation of radicals from arte- 
misinin (F. Kuypers, unpublished results). The mechar- 
ism of iron-mediated decomposition has recently been 
elucidated (POSNER & OH, 1992). In aggregate, these 
data indicate that iron activates artemisinin into a free 
radical. 
There is stron 
d 
evidence that the antimalarial activities 
of these drugs epend on the generation of free radical 
intermediates. Free radical scavengers such as ascorbic 
acid and vitamin E antagonize the antimalarial activities 
of the drug both in vitro (KRUNGKRAI & YUTHAVONG, 
1987; MESHNICK et al., 1989) and in viva (LWANDER et 
al., 1989). However, the free radical intermediate, once 
formed, may structurally rearrange to produce other re- 
active and electrophilic intermediates (POSNER & OH, 
1992). 
Drue activation bv iron and haem tnav exolain whv 
endop&xides are s&ctively toxic to m&ia’parasit& 
Malaria parasites live in a ‘sea’ of haem-iron (the red cell 
is 95% haemaglobin, or 20 rn~ haem), which they event- 
ually convert into insoluble haemozin. The observation 
that chloroouine-resistant Plasmodium bewkez, which 
lacks visibl; haemozoin. is resistant to -art&nisinin 
(PETERS et al., 1986) suggests that active haemozoin bio- 
svnthesis is essential for drue activitv. 
’ There are several different iron &~ls in the infected 
red blood cell which might be responsible for drug acti- 
vation (Fig. 2). In the food vacuole, haemoglobin is in 
the process of being broken down, releasing haem. The 
haem, in turn is in the process of being polymerized into 
haemozoin. There may also be free iron formed (H. 
Ginsburg, Hebrew University, personal communica- 
tion). Fmally, there are haemoproteins (i.e., cyto- 
chromes) in the mitochondria. Which of these iron pools 
is responsible for catalysing the decomposition of arte- 
misinin *n vtuo? 
In vitro, artemisinin reacts poorly or not at all when 
mixed with either haemoglobin or haemozoin, suggesting 
that these pools may not be important. In contrast, arte- 
misinin is activated suite well bv haem and free iron 
(MESHNICK et al., lhl, 1993; ~‘OSNER et al., 1992; 
ZHANG et al., 1992). The observation that chloraquine, 
which binds haem (CHOU et al., 1980), antagonizes the 
antimalarial activity of artemisinin against P. falcipancm 
(see STAHEL et& 1988) suggests that the free haem pool 
may be important. Similarly, the observation that iron 
chelators, which bind free iron, are antagonistic, suggests 
that free iron may be important (KAMCHONWONGPAISAN 
et al., 1992; MESHNICK et al., 1993). However, smne 
iron chelators also bind haem. Thus, it appears that the 
transient pools of haem and free iron may be responsible 
for activating artemisinin m ozw. 
Alkylation 
After the drug is converted 10 a reactive free radical it 
can then form covalent bonds with proteins. The reac- 
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tions of both [tQwtemisinin and [~H]dihydroattemis- 
inin with proteins have been studied m 2 model sys- 
terns-hun&n serum and isolated red cell membranes. 
Radiolabelled artemisinin covalently reacts with 
human serum albumin in a time-dependent fashion, pre- 
dominantly forming bonds with free amino groups 
(YANG et al., 1993). There are both iron-dependent and 
iron-independent reactions. The covalent nature of the 
adduct was demonstrated by sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis and by electrospray 
mass spectrometry (YANG et al., 1993). Radiolabelled 
drug is also taken up by isolated red cell membranes, 
where it forms covalent bonds with various membrane 
proteins such as wspectrin, P-spectrin, band 3, band 
4.1,4,2, actin and glyceraldehyde phosphate dehydroge- 
nase. In contrast, when artemisinin is incubated with m- 
tact erythrocytes, there is no uptake or protein alkylation 
iW. Asawamahasakda et al.. tu.~er submitted for mtbli- 
submitted for publication). 
Once taken into the parasite, [3H]dihydroartemisinin 
concentrates in the haemozoin. In addition, several mala- 
ria-specific proteins are alkylated (W. Asawamahasakda 
et al., paper submitted for publication). 
Other effects of artemisinin 
Electron microgra hs have demonstrated that the ear- 
liest pathological e f? ects of artemisinin are on parasite 
membranes and mitochondria, as well as on food vac- 
uoles (MAENO et al., 1993). The effects on membranes 
and mitochondria may be secondary to the toxic effects 
of the drug on the food vacuole, or they may be due to 
activation and alkylation reactions occurring at those 
sites. 
Very high concentrations of artemisinin (0.1-I mht) 
cause oxidation of red blood cell membrane proteins and 
decreases in red cell deformability, especially in the 
presence of exogenous haem (SCOTT et al., 1989; MESN- 
NICK et al., 1991, 1993), suggesting that the drug may af- 
fect plasma membrane fimcuon in infected erythtocytes. 
However, no such effect has been seen at therapeutic 
drug concentrations. 
Effects of endoperoxides on the host 
The mechanisms described above may also explain 
some of the drug’s effects on the host (BREWER et al., 
1992). Iron-mediated activation of endoperoxides may 
play a role in host toxicity since an iron chelator has been 
shown to prolong survival in mice given lethal doses of 
artemisinin (MESHNICK et al., 1993). In addition, the fa- 
cile reactions between artemisinin and host proteins may 
play a role in the rapid disappearance of the drug from 
the blood-stream. 
Summary 
The endoperoxides represent a new class of antimala- 
rial agents, which are entirely unrelated to any of the 
other currently available drugs. Insight into their mech- 
anisms of action can aid in the design of new and more 
effective derivatives. 
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